BNP Paribas Financial Markets’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $236M | Sell |
|
|||||
|
2025
Q1 | $285M | Sell |
|
|||||
|
2024
Q4 | $240M | Buy |
|
|||||
|
2024
Q3 | $206M | Sell |
|
|||||
|
2024
Q2 | $248M | Buy |
|
|||||
|
2024
Q1 | $217M | Buy |
|
|||||
|
2023
Q4 | $160M | Buy |
|
|||||
|
2023
Q3 | $107M | Sell |
|
|||||
|
2023
Q2 | $130M | Buy |
|
|||||
|
2023
Q1 | $87.9M | Buy |
|
|||||
|
2022
Q4 | $71.7M | Buy |
|
|||||
|
2022
Q3 | $54.3M | Sell |
|
|||||
|
2022
Q2 | $84M | Buy |
|
|||||
|
2022
Q1 | $70.1M | Buy |
|
|||||
|
2021
Q4 | $37.4M | Buy |
|
|||||
|
2021
Q3 | $23M | Sell |
|
|||||
|
2021
Q2 | $34M | Sell |
|
|||||
|
2021
Q1 | $73.1M | Buy |
|
|||||
|
2020
Q4 | $44M | Sell |
|
|||||
|
2020
Q3 | $64M | Buy |
|
|||||
|
2020
Q2 | $56M | Buy |
|
|||||
|
2020
Q1 | $27.9M | Buy |
|
|||||
|
2019
Q4 | $19.7M | Sell |
|
|||||
|
2019
Q3 | $18M | Sell |
|
|||||
|
2019
Q2 | $30.5M | Sell |
|
|||||
|
2019
Q1 | $34.1M | Buy |
|
|||||
|
2018
Q4 | $11M | Sell |
|
|||||
|
2018
Q3 | $29.5M | Sell |
|
|||||
|
2018
Q2 | $28.2M | Buy |
|
|||||
|
2018
Q1 | $10.3M | Sell |
|
|||||
|
2017
Q4 | $29.7M | Buy |
|
|||||
|
2017
Q3 | $16.6M | Sell |
|
|||||
|
2017
Q2 | $18M | Sell |
|
|||||
|
2017
Q1 | $24.9M | Buy |
|
|||||
|
2016
Q4 | $8.07M | Sell |
|
|||||
|
2016
Q3 | $9.69M | Sell |
|
|||||
|
2016
Q2 | $13M | Buy |
|
|||||
|
2016
Q1 | $7.91M | Sell |
|
|||||
|
2015
Q4 | $18.4M | Buy |
|
|||||
|
2015
Q3 | $12.3M | Sell |
|
|||||
|
2015
Q2 | $29.2M | Buy |
|
|||||
|
2015
Q1 | $20.8M | Sell |
|
|||||
|
2014
Q4 | $27.3M | Sell |
|
|||||
|
2014
Q3 | $70.5M | Sell |
|
|||||
|
2014
Q2 | $64.2M | Buy |
|
|||||
|
2014
Q1 | $16.8M | Sell |
|
|||||
|
2013
Q4 | $30M | Buy |
|
|||||
|
2013
Q3 | $30M | Buy |
|
|||||
|
2013
Q2 | $12.9M | Buy |
|